TNF and infection: This agrees with data from the Swedish practice-based registry ARTIS (AntiRheumatic Therapies In Sweden), which indicate that there is a slight increase in the risk of infection in RA patients treated with anti-TNF-α agents but that it is not driven by any particular type of infection [27].